Code | 34009 | ||||||||||
MA number | 44/0356/00-S | ||||||||||
Product Form: | sol inj 1x5 ml/10 mg (liek.PP - povolenie uvádzať na trh končí dňa 31.07.2024) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 31.10.2000 |
SPC: | SPC_FARMORUBICIN PFS_05.2024.pdf |
PIL: | PIL_FARMORUBICIN PFS_05.2024.pdf |
Safety feature | Yes |
Data update: | 30.04.2024 |